MSCs-exosomes in regeneration medicine: Current evidence and future perspectives

2Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Exosomes, especially from mesenchymal stem cells, have attracted extensive attention in regeneration medicine. Mesenchymal stem cells derived exosomes (MSCs-exosomes) have shown anti-inflammatory, anti-oxidant, antiapoptosis and tissue regeneration effects in a variety of tissue injury repair models. MSCs-exosomes hold many excellent properties such as low immunogenicity, biocompatibility, and targeting capability. With the in-depth study on the generation and function of exosomes, MSCs-exosomes are considered to be the bright stars in the field of regenerative medicine. However, there are still many obstacles to overcome in terms of exosomes isolation, clinical trials and safety evaluation. In this article, what we should focus on about MSCs-exosomes in regeneration medicine will be discussed.

Cite

CITATION STYLE

APA

You, B., & Qian, H. (2022). MSCs-exosomes in regeneration medicine: Current evidence and future perspectives. Biocell, 46(6), 1459–1463. https://doi.org/10.32604/biocell.2022.018378

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free